Breaking News, Financial News

Financial Report: PAREXEL 2Q

Consolidated service revenue for quarter was $221.6 million in Clinical Research Services (CRS), $29.7 million in PAREXEL Consulting and Medical Communications Services (PCMS), and $33.4 million in Perceptive Informatics, Inc.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

PAREXEL 2Q 2Q Revenues: $284.7 million (+3%) 2Q Earnings: $3.5 million (-33%) YTD Revenues: $544.5 million (+1%) YTD Earnings: $15.9 million (-15%) Comments: Consolidated service revenue for quarter was $221.6 million in Clinical Research Services (CRS), $29.7 million in PAREXEL Consulting and Medical Communications Services (PCMS), and $33.4 million in Perceptive Informatics, Inc. Restructuring and related charges in the quarter were $14.3 million, including costs for severance a...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters